SCHEMBL20037553

SCHEMBL20037553

CN(C)c1cnc(CN2CCNCC2)cn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 8/20 0.41
KDM5C P41229 1/20 0.40
KDM4C Q9H3R0 1/20 0.40
SIGMAR1 Q99720 1/20 0.39
LMNA P02545 1/20 0.37
CHRM2 P08172 2/20 0.37
CYP1A2 P05177 1/20 0.37
SLC6A4 P31645 1/20 0.37
OPRD1 P41143 1/20 0.37
OPRK1 P41145 1/20 0.37
APOBEC3A P31941 1/20 0.36
CTDSP1 Q9GZU7 1/20 0.36
APOBEC3G Q9HC16 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
CHRM1 P11229 1/20 0.36
ADRA2C P18825 1/20 0.36
CCR2 P41597 1/20 0.36
CXCL12 P48061 1/20 0.36
BLM P54132 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20038507 0.81 CXCR4 (0.44) CXCR4KDM5CKDM4CSIGMAR1LMNA
SCHEMBL22642421 0.78 CXCR4 (0.47) CXCR4SIGMAR1CHRM2MEN1KMT2A
SCHEMBL20255286 0.77 CXCR4 (0.43) CXCR4KDM5CKDM4CSIGMAR1LMNA
SCHEMBL20249430 0.76 CXCR4 (0.40) CXCR4KDM5CKDM4CSIGMAR1LMNA
SCHEMBL20160684 0.72 CXCR4 (0.49) CXCR4KDM5CKDM4CSIGMAR1LMNA
SCHEMBL3148862 0.71 CXCR4 (0.50) CXCR4KDM5CKDM4CSIGMAR1LMNA
SCHEMBL32667730 0.71 CYP11B1 (0.51) CXCR4KDM5CKDM4CSIGMAR1LMNA
SCHEMBL211045 0.70 HRH3 (0.44) CXCR4KDM5CKDM4CSIGMAR1LMNA
SCHEMBL3065752 0.69 CXCR4 (0.45) CXCR4KDM5CKDM4CSIGMAR1LMNA
SCHEMBL13764446 0.69 CXCR4 (0.45) CXCR4KDM5CKDM4CSIGMAR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3305785-A1 PYRIDO[3,4-d]PYRIMIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF Teijin Pharma Limited (JP) 2018-04-11 EP disclosed